Dataset
Vildagliptin
Chemical Info
InChI | InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12?,13?,14-,16?,17?/m0/s1 |
---|---|
SMILES | C1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N |
InChI Key | SYOKIDBDQMKNDQ-XWTIBIIYSA-N |
Molecular Formula | C17H25N3O2 |
Exact Mass | 303.195 g/mol |
Data and Resources
Metadata Information
Field | Value |
---|---|
DOI | |
License URL | |
Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU226631 |
Version | |
Author | |
Maintainer | |
Language | |
MetadataCreated | 2024-01-11T09:48:01.740761 |
MetadataModified | 2024-01-11T09:48:01.904235 |
MetadataPublished | 2016-02-28 |
Field | Value |
---|---|
Measurement Technique | liquid chromatography-mass spectrometry |
Measurement Variables |
Data-Source Molecule ID | Data-Source |
---|---|
6918537 | PubChem |
PD009355 | ProbesDrugs |
GALVUS | clinicaltrials |
14898545 | PubChem: Thomson Pharma |
vildagliptin-laf-237 | Selleck |
14849686 | PubChem: Thomson Pharma |
PA165958346 | PharmGKB |
MolPort-006-167-819 | MolPort |
CB71449010 | ChemicalBook |
151480 | Brenda |
58976 | Brenda |
25034 | Brenda |
HMDB0015596 | Human Metabolome Database |
64118 | Brenda |
39902 | Brenda |
75289 | Brenda |
DTXSID80881091 | EPA CompTox Dashboard |
DB04876 | DrugBank |
28294452 | eMolecules |
CHEMBL142703 | ChEMBL |
12015446 | PubChem: Drugs of the Future |
VILDAGLIPTIN | clinicaltrials |
3642 | DrugCentral |
135285 | ChEBI |
I6B4B2U96P | FDA SRS |
LAF237 | clinicaltrials |
LAF-237 | clinicaltrials |
NVP-LAF 237 | clinicaltrials |
NVP-LAF237 | clinicaltrials |
VILDAGLIPTIN | rxnorm |
SCHEMBL16579 | SureChEMBL |
6310 | Guide to Pharmacology |
11695 | BindingDB |
The data in this table is sourced from UniChem at EBI. |